Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul Holst
Briefly

Holst, Habener, Mojsov, Drucker's work on GLPs since the 1970s led to obesity treatments like Ozempic, Wegovy, Mounjaro, Zepbound, revolutionizing health care.
Collaboration among scientists uncovered GLP-1's role in insulin regulation, paving the way for diabetes and obesity treatment breakthroughs with GLP-1 based medicines.
Read at time.com
[
add
]
[
|
|
]